No profile data available.
Aida Pharmaceuticals, Inc. (AIDA) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Hangzhou, China, with about 450 full-time employees.
It reported revenue of $29.20 million for fiscal year 2007, down 1.5% from fiscal year 2006, and net income of $2.74 million. In Q3 2008 (the quarter ended September 30, 2008) revenue was $11.89 million, up 61.2% from a year before. Its market capitalization was $12.56 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2007; market data as of October 8, 2026.
, together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs.
Aida Pharmaceuticals reported $29.20 million in revenue for fiscal year 2007, down 1.5% from $29.64 million in fiscal year 2006. In Q3 2008 revenue was $11.89 million.
$12.56 million as of October 8, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Jasper Therapeutics, Inc. (JSPR), Zenith Capital Corp. (ZHCLF), Vyome Holdings, Inc. (HIND), Fluent Corp. (CNTMF).